Balanced news tone
News Sentiment
BONS sentiment intelligence
Bonus BioGroup Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-5.1% over one week, -14.6% over four weeks, trend inactive, and materially above fair value.
Price to book forward of Bonus Biogroup Ltd. – NASDAQ:BONS
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Price to book forward of Bonus Biogroup Ltd. – NASDAQ:BONS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jul 2026 16:15
- Source
- TradingView
Israel-listed cell therapy biotech Bonus Biogroup increases shares offered by 25% ahead of $19 million US IPO
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- renaissancecapital.com
Retail investors who hold 54% of Bonus BioGroup Ltd. (TLV:BONS) gained 19%, insiders profited as well
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jan 2026 08:00
- Source
- simplywall.st